Maternal Immune Responsiveness As CLinical Target for Preterm Birth Prevention (MIRACL)
$53,986K23FY2020NRNIH
Ohio State University, Columbus OH
Investigators
Linked publications & trials
Abstract
Project Summary/Abstract Not applicable for supplement application
View original record on NIH RePORTER →